Ignite Creation Date:
2025-12-24 @ 2:00 PM
Ignite Modification Date:
2025-12-27 @ 9:56 PM
Study NCT ID:
NCT00765895
Status:
COMPLETED
Last Update Posted:
2020-05-14
First Post:
2008-10-02
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Nortriptyline for Idiopathic Gastroparesis
Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Organization:
Study Overview
Official Title:
Nortriptyline for Idiopathic Gastroparesis: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial (NORIG)
Status:
COMPLETED
Status Verified Date:
2020-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NORIG
Brief Summary:
The principal objective of this multicenter, randomized, placebo-controlled trial is to evaluate whether treatment with nortriptyline will improve gastroparesis symptoms compared with placebo.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 1U01DK073983 | NIH | None | https://reporter.nih.gov/quic… | View |
| 1U01DK073975 | NIH | None | https://reporter.nih.gov/quic… | View |
| 1U01DK073985 | NIH | None | https://reporter.nih.gov/quic… | View |
| 1U01DK074007 | NIH | None | https://reporter.nih.gov/quic… | View |
| 1U01DK073974 | NIH | None | https://reporter.nih.gov/quic… | View |
| 1U01DK074008 | NIH | None | https://reporter.nih.gov/quic… | View |